secwatch / observer
8-K filed March 12, 2024, 7:59 PM ET ticker SKIN CIK 0001818093
earnings confidence high sentiment negative materiality 0.80

BeautyHealth Q4 net sales $96.8M (-1.3% YoY); full year net loss $100.1M

SkinHealth Systems Inc.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

SkinHealth Systems Inc. reported the fiscal year ended December 31, 2023 results: revenue $398.0 million, net income $(100.1) million.

Period
the fiscal year ended December 31, 2023
Revenue
$398.0 million
Net income
$(100.1) million
Result
reported results
Exact text from the filing
with its disclosure obligations under Regulation FD. --- EX-99.1 (EX-99.1) --- BeautyHealth Reports Full Year and Fourth Quarter 2023 Financial Results Delivers net sales of $398 million for the full year and $96.8 million for the fourth quarter driven by growth across international markets Long Beach, Calif., March 12, 2024 – The Beauty Health Company (NASDAQ:
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.95

SkinHealth Systems Inc. reported the fourth quarter ended December 31, 2023 results: revenue $96.8 million, net income $(9.4) million.

Period
the fourth quarter ended December 31, 2023
Revenue
$96.8 million
Net income
$(9.4) million
Result
reported results
Exact text from the filing
Regulation FD. --- EX-99.1 (EX-99.1) --- BeautyHealth Reports Full Year and Fourth Quarter 2023 Financial Results Delivers net sales of $398 million for the full year and $96.8 million for the fourth quarter driven by growth across international markets Long Beach, Calif., March 12, 2024 – The Beauty Health Company (NASDAQ: SKIN) (“BeautyHealth”), home to
View on SEC.gov

171 earnings releases filed in the last 30 days. Browse all earnings releases →

SkinHealth Systems Inc. filing history →

Source: SEC EDGAR
accession 0001628280-24-010538
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.